Viracta TherapeuticsVIRX
13F holders, Q4 2025 (December 31)1holders −6
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Viracta Therapeutics Inc. (VIRX) in their 13F filings, down 6 from Q1 2025. 1 opened new positions and 0 sold out. The largest holder was Motiv8 Investments LLC ($0).
- Company
- Viracta Therapeutics Inc.
- CUSIP
- 92765F108
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q4 2025: 14 shares bought, net +14 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Motiv8 Investments LLC | 0.00% | New | 14 | $0 |
"% of holder's portfolio" is VIRX's weight in each manager's 13F, not the share of Viracta Therapeutics Inc. the manager owns.